FDA.reportPublic FDA data

insulin, aspart, human 100 UNT/ML per 3 ML Cartridge

RxCUI
1653196
RxNorm name
insulin, aspart, human 100 UNT/ML per 3 ML Cartridge
Display name
insulin, aspart, human 100 UNT/ML per 3 ML Cartridge
Full name
insulin, aspart, human 100 UNT/ML per 3 ML Cartridge
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
020986Novologinsulin aspart351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NOVOLOGINSULIN ASPARTA-S Medication Solutionse172b4f8-9b25-4019-8e09-afc10b2f30c92023-12-09Warnings, Adverse reactionsExact identifier
rxcui: 1653196
Insulin AspartINSULIN ASPARTNovo Nordisk Pharma, Inc.bee5b358-c863-420b-be73-ced2e920c4992023-02-28Warnings, Adverse reactionsExact identifier
rxcui: 1653196
Insulin Diluting Medium for NovoLogWATER INJECTIONNovo Nordisk3a1e73a2-3009-40d0-876c-b4cb2be56fc52023-02-28Warnings, Adverse reactionsExact identifier
rxcui: 1653196

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3a1e73a2-3009-40d0-876c-b4cb2be56fc5insulin aspart 100 UNT/ML in 3 ML Cartridge [PSN] · 3 ML insulin aspart, human 100 UNT/ML Cartridge [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Cartridge [SY]334These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 200020230228
e172b4f8-9b25-4019-8e09-afc10b2f30c9insulin aspart 100 UNT/ML in 3 ML Cartridge [PSN] · 3 ML insulin aspart, human 100 UNT/ML Cartridge [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Cartridge [SY]328These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 200020231209
bee5b358-c863-420b-be73-ced2e920c499insulin aspart 100 UNT/ML in 3 ML Cartridge [PSN] · 3 ML insulin aspart, human 100 UNT/ML Cartridge [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Cartridge [SY]35These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART. INSULIN ASPART injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 This product is NovoLog (insulin aspart).20230228